Dr. Van Gieson has over 25 years of experience in developing medical technology in therapeutics, diagnostics and critical care with leadership roles in industry, academia, and Government. Most recently, Dr. Van Gieson served as a Program Manager for the Defense Advanced Research Projects Agency (DARPA), where he initiated programs to use host-based methods to mitigate the impacts of emerging diseases, as well as to optimize human performance. At DARPA, Dr. Van Gieson deployed multiple products into clinical use in therapeutic and diagnostic applications, enabling a new diagnostic paradigm that harnesses the epigenome with AI/ML-based biological pathway analyses. This work has led to new technologies that can both diagnose and prognose diseases, guide healthcare decisions, optimize human performance, and enable discovery of new medical therapies based upon host pathway modulation. In addition, Dr. Van Gieson created programs at DARPA to prevent traumatic brain injury with molecular prophylaxes. Eric’s diverse roles in industry have included Chief Technology Officer at the National Strategic Research Institute (NSRI, a STRATCOM UARC) as well as Director of Biosurveillance and Diagnostics at MRIGlobal. In these positions, Dr. Van Gieson worked together with private and interagency partners to develop a novel patient transport system, known as the Containerized BioContainment System (CBCS). This platform ultimately received an R&D 100 award and is currently in use by the Department of State, Department of Defense, and has served critical roles in transport of civilian/military patients in both Ebola and COVID-19 outbreaks. Dr. Van Gieson also served as Chief of the Diagnostics, Disease Surveillance, and Threat Detection Division within the Defense Threat Reduction Agency (DTRA), and as Principal Professional Staff at the Johns Hopkins Applied Physics Laboratory (JHUAPL). Dr. Van Gieson received his Doctor of Philosophy degree in Biomedical Engineering and a Bachelor of Science degree in Chemical Engineering from the University of Virginia.
Back to Team